NYSE:AVNS AVANOS MEDICAL (AVNS) Stock Price, News & Analysis $10.72 +0.39 (+3.73%) Closing price 08/7/2025 03:59 PM EasternExtended Trading$10.74 +0.03 (+0.23%) As of 08/7/2025 05:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About AVANOS MEDICAL Stock (NYSE:AVNS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get AVANOS MEDICAL alerts:Sign Up Key Stats Today's Range$10.26▼$10.8150-Day Range$9.98▼$12.8752-Week Range$9.30▼$25.36Volume814,655 shsAverage Volume575,957 shsMarket Capitalization$497.18 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia. Read More AVANOS MEDICAL Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks33rd Percentile Overall ScoreAVNS MarketRank™: AVANOS MEDICAL scored higher than 33% of companies evaluated by MarketBeat, and ranked 748th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for AVANOS MEDICAL. Earnings and Valuation2.5 / 5Proj. Earnings Growth31.06% Earnings GrowthEarnings for AVANOS MEDICAL are expected to grow by 31.06% in the coming year, from $1.32 to $1.73 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of AVANOS MEDICAL is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of AVANOS MEDICAL is -1.06, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAVANOS MEDICAL has a P/B Ratio of 0.64. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.37% of the float of AVANOS MEDICAL has been sold short.Short Interest Ratio / Days to CoverAVANOS MEDICAL has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AVANOS MEDICAL has recently increased by 3.42%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAVANOS MEDICAL does not currently pay a dividend.Dividend GrowthAVANOS MEDICAL does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.37% of the float of AVANOS MEDICAL has been sold short.Short Interest Ratio / Days to CoverAVANOS MEDICAL has a short interest ratio ("days to cover") of 3.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in AVANOS MEDICAL has recently increased by 3.42%, indicating that investor sentiment is decreasing. News and Social Media1.0 / 5News Sentiment-0.21 News SentimentAVANOS MEDICAL has a news sentiment score of -0.21. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for AVANOS MEDICAL this week, compared to 3 articles on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, AVANOS MEDICAL insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.64% of the stock of AVANOS MEDICAL is held by insiders.Percentage Held by Institutions95.17% of the stock of AVANOS MEDICAL is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about AVANOS MEDICAL's insider trading history. Receive AVNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for AVANOS MEDICAL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVNS Stock News HeadlinesAvanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call TranscriptAugust 7 at 3:25 AM | msn.comAvanos Medical (NYSE:AVNS) Hits New 1-Year Low on Disappointing EarningsAugust 7 at 2:27 AM | americanbankingnews.comCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbling. But for smart traders, this isn’t chaos. It’s opportunity. One veteran trader is revealing how his simple system spots fast setups in moments like this—no guesswork, no complicated strategies, and no big account required. | Timothy Sykes (Ad)Avanos Medical, Inc. (AVNS) Q2 2025 Earnings Call TranscriptAugust 5 at 2:16 PM | seekingalpha.comAvanos Medical, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 5 at 1:26 PM | seekingalpha.comAvanos (AVNS) Q2 2025 Earnings Call TranscriptAugust 5 at 12:57 PM | fool.comAvanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of DirectorsAugust 5 at 6:45 AM | prnewswire.comAvanos Medical, Inc. Announces Second Quarter 2025 ResultsAugust 5 at 6:30 AM | prnewswire.comSee More Headlines AVNS Stock Analysis - Frequently Asked Questions How have AVNS shares performed this year? AVANOS MEDICAL's stock was trading at $15.92 at the start of the year. Since then, AVNS shares have decreased by 32.7% and is now trading at $10.7150. How were AVANOS MEDICAL's earnings last quarter? AVANOS MEDICAL, INC. (NYSE:AVNS) posted its quarterly earnings data on Tuesday, August, 5th. The company reported $0.17 EPS for the quarter, missing analysts' consensus estimates of $0.18 by $0.01. The firm had revenue of $175 million for the quarter, compared to analysts' expectations of $165.50 million. AVANOS MEDICAL had a negative net margin of 66.89% and a positive trailing twelve-month return on equity of 6.16%. Read the conference call transcript. Who are AVANOS MEDICAL's major shareholders? Top institutional investors of AVANOS MEDICAL include Tributary Capital Management LLC (1.75%), Acadian Asset Management LLC (0.57%), Envestnet Asset Management Inc. (0.45%) and Kestrel Investment Management Corp (0.32%). Insiders that own company stock include Michael Greiner, Kerr Holbrook and Julie Ann Shimer. View institutional ownership trends. How do I buy shares of AVANOS MEDICAL? Shares of AVNS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of AVANOS MEDICAL own? Based on aggregate information from My MarketBeat watchlists, some other companies that AVANOS MEDICAL investors own include JPMorgan Chase & Co. (JPM), Meta Platforms (META), NVIDIA (NVDA), Advanced Micro Devices (AMD), Home Depot (HD), Netflix (NFLX) and Tesla (TSLA). Company Calendar Last Earnings8/05/2025Today8/07/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry MED INSTRUMENTS Sub-IndustryMedical Equipment Current SymbolNYSE:AVNS CIK1606498 Webavanos.com Phone(844) 428-2667FaxN/AEmployees2,227Year FoundedN/AProfitability EPS (Trailing Twelve Months)($10.07) Trailing P/E RatioN/A Forward P/E Ratio8.12 P/E GrowthN/ANet Income-$392.10 million Net Margins-66.89% Pretax Margin-68.91% Return on Equity6.16% Return on Assets4.57% Debt Debt-to-Equity Ratio0.12 Current Ratio2.64 Quick Ratio1.56 Sales & Book Value Annual Sales$687.80 million Price / Sales0.72 Cash Flow$12.32 per share Price / Cash Flow0.87 Book Value$16.73 per share Price / Book0.64Miscellaneous Outstanding Shares46,400,000Free Float45,023,000Market Cap$497.18 million OptionableOptionable Beta1.12 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NYSE:AVNS) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | SponsoredThe Day Silicon DiesThe Day China Left America's Supercomputers in the Dust In 200 seconds, China's quantum computer accomplish...The Oxford Club | SponsoredThis accelerated income plan is solving American's #1 retirement fearThe #1 fear in retirement today? Running out of money. That’s why income expert Tim Plaehn created a simple...Investors Alley | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AVANOS MEDICAL, INC. Please log in to your account or sign up in order to add this asset to your watchlist. Share AVANOS MEDICAL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.